Health ❯Healthcare ❯Cancer ❯Treatment

Clinical Trials

Camizestrant Cuts Breast Cancer Progression Risk by Over Half in Global Trial

Liquid biopsy-guided treatment extended progression-free survival from nine to 16 months

Keynote-689 Trial Finds Pembrolizumab Doubles Disease-Free Survival in Head and Neck Cancer

Trump Administration Pauses Public Health Agency Operations, Delays Research Funding